| Source: |
| Type: |
| DYRK1A is a central, upstream kinase in Alzheimer’s disease that links tau hyperphosphorylation, amyloid production, autophagy/mitophagy impairment, and neuroinflammation.
Its overactivity—whether due to aging, stress signaling, or chromosome 21 gene dosage—pushes neurons toward mitochondrial failure and degeneration. -Increased DYRK1A expression/activity in AD brains -Strong overexpression in Down syndrome with early-onset AD Animal models DYRK1A overexpression: -Increases tau phosphorylation -Worsens cognitive performance DYRK1A inhibition: -Reduces tau pathology -Improves synaptic and cognitive outcomes -Enhances autophagic markers |
| 4872- | Uro, | Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity |
| - | in-vitro, | AD, | HEK293 |
| 4867- | Uro, | Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity |
| - | in-vivo, | AD, | NA | - | in-vitro, | AD, | HEK293 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1407 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid